Karuna Therapeutics, Inc. (Nasdaq: KRTX), a clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with disabling and potentially fatal neuropsychiatric disorders and pain, today announced that Steve Paul, M.D., chief executive officer, president and chairman of Karuna Therapeutics, will present at the Cowen and Company’s 40th Annual Health Care Conference being held at the Boston Marriott Copley Place in Boston, MA.
A live webcast of the presentation will also be available on the investor relations page of the Karuna corporate website at investors.karunatx.com. After the live webcast, the event will remain archived on the Karuna website for 90 days.
About Karuna
Karuna is a clinical-stage biopharmaceutical company committed to developing and delivering first-in-class therapies with the potential to transform the lives of people with CNS disorders – which remain among the most disabling and potentially fatal disorders worldwide. Galvanized by the understanding that today’s neuropsychiatric and pain management patients deserve better, Karuna’s mission is to harness the untapped potential of the brain’s complex biology in pursuit of novel therapeutic pathways that will advance the standard of care. For more information, please visit karunatx.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200225005144/en/
Contacts
Investors:
Chris Brinzey
Westwicke, an ICR Company
+1 339 970-2843
chris.brinzey@westwicke.com
Media:
Jenn Gordon
GlobalHealthPR
+1 202 587-2580
jgordon@globalhealthpr.com
Source: Karuna Therapeutics, Inc.
View this news release online at:
http://www.businesswire.com/news/home/20200225005144/en
